1. Home
  2. PTGX vs LBTYA Comparison

PTGX vs LBTYA Comparison

Compare PTGX & LBTYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • LBTYA
  • Stock Information
  • Founded
  • PTGX 2006
  • LBTYA 2004
  • Country
  • PTGX United States
  • LBTYA Bermuda
  • Employees
  • PTGX N/A
  • LBTYA N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • LBTYA Cable & Other Pay Television Services
  • Sector
  • PTGX Health Care
  • LBTYA Telecommunications
  • Exchange
  • PTGX Nasdaq
  • LBTYA Nasdaq
  • Market Cap
  • PTGX 3.3B
  • LBTYA 3.7B
  • IPO Year
  • PTGX 2016
  • LBTYA N/A
  • Fundamental
  • Price
  • PTGX $58.97
  • LBTYA $11.74
  • Analyst Decision
  • PTGX Strong Buy
  • LBTYA Buy
  • Analyst Count
  • PTGX 8
  • LBTYA 5
  • Target Price
  • PTGX $70.13
  • LBTYA $14.96
  • AVG Volume (30 Days)
  • PTGX 646.3K
  • LBTYA 1.8M
  • Earning Date
  • PTGX 08-06-2025
  • LBTYA 10-28-2025
  • Dividend Yield
  • PTGX N/A
  • LBTYA N/A
  • EPS Growth
  • PTGX N/A
  • LBTYA N/A
  • EPS
  • PTGX 0.80
  • LBTYA N/A
  • Revenue
  • PTGX $209,180,000.00
  • LBTYA $4,633,000,000.00
  • Revenue This Year
  • PTGX N/A
  • LBTYA $10.21
  • Revenue Next Year
  • PTGX $185.11
  • LBTYA $1.04
  • P/E Ratio
  • PTGX $73.40
  • LBTYA N/A
  • Revenue Growth
  • PTGX N/A
  • LBTYA 81.79
  • 52 Week Low
  • PTGX $33.31
  • LBTYA $9.03
  • 52 Week High
  • PTGX $61.89
  • LBTYA $21.56
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 57.69
  • LBTYA 69.85
  • Support Level
  • PTGX $55.26
  • LBTYA $11.54
  • Resistance Level
  • PTGX $58.79
  • LBTYA $11.86
  • Average True Range (ATR)
  • PTGX 2.20
  • LBTYA 0.25
  • MACD
  • PTGX 0.39
  • LBTYA 0.00
  • Stochastic Oscillator
  • PTGX 66.84
  • LBTYA 86.36

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About LBTYA Liberty Global Ltd.

Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

Share on Social Networks: